The Royal Pharmaceutical Society (RPS) said despite the "incredibly exciting age" we live in, the market is "not set up to incentivise the production of new types of medicines".
RPS chief scientist Professor Jayne Lawrence said: "The current crisis in antimicrobial resistance is in part due to the lack of new classes of antibiotics coming on the market.
"Antibiotics can cure infections in weeks, so the volume of sales of drugs is low. This doesn't allow the tens or even hundreds of millions required for research and development to be recouped.
"Unless we find a way to develop treatments that cure illnesses in months, rather than treat symptoms for years, we will not see the breakthroughs that both scientists and patients want."
More top news
Syrian rebels have reportedly detonated car bombs and launched more than 150 rockets in a major counter attack from eastern Aleppo.
The 48-year-old mother-of-two plummeted to her death during a South African holiday when a gust flipped over the basket.
If you've ever wondered what the world looks like through the eyes of a child, look no further than the Instagram feed Things I have drawn.